<DOC>
	<DOCNO>NCT00157976</DOCNO>
	<brief_summary>The purpose study confirm efficacy safety rostaporfin ( PHOTREX ) photodynamic therapy ( PDT ) treatment classic occult subfoveal choroidal neovascularization ( CNV ) associate age-related macular degeneration ( AMD ) .</brief_summary>
	<brief_title>Double-Masked Study Photrex ( Rostaporfin ) Photodynamic Therapy Treatment Age-Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<criteria>Patients age great equal 50 year least one subfoveal CNV membrane secondary AMD demonstrate fluorescein angiography .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Macular Degeneration</keyword>
	<keyword>AMD</keyword>
	<keyword>Visual Acuity</keyword>
</DOC>